LOXO Trademark

Trademark Overview


On Thursday, November 9, 2017, a trademark application was filed for LOXO with the United States Patent and Trademark Office. The USPTO has given the LOXO trademark a serial number of 87678521. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by Loxo Oncology, Inc.. The LOXO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
loxo

General Information


Serial Number87678521
Word MarkLOXO
Filing DateThursday, November 9, 2017
Status700 - REGISTERED
Status DateTuesday, June 11, 2019
Registration Number5776463
Registration DateTuesday, June 11, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 20, 2017
Primary Code005
First Use Anywhere DateFriday, March 15, 2019
First Use In Commerce DateFriday, March 15, 2019

Trademark Owner History


Party NameLoxo Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStamford, CT 06901

Party NameLoxo Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStamford, CT 06901

Party NameLoxo Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStamford, CT 06901

Trademark Events


Event DateEvent Description
Friday, December 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 13, 2017NEW APPLICATION ENTERED
Monday, November 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 22, 2017ASSIGNED TO EXAMINER
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 13, 2018SOU TEAS EXTENSION RECEIVED
Thursday, September 13, 2018SOU EXTENSION 1 FILED
Thursday, September 13, 2018SOU EXTENSION 1 GRANTED
Saturday, September 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 26, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, February 26, 2019SOU EXTENSION 2 FILED
Tuesday, February 26, 2019SOU EXTENSION 2 GRANTED
Thursday, February 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2019TEAS STATEMENT OF USE RECEIVED
Monday, March 18, 2019USE AMENDMENT FILED
Wednesday, April 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 3, 2019STATEMENT OF USE PROCESSING COMPLETE
Saturday, May 4, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 3, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Friday, August 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED